Skip to main content

ADVERTISEMENT

Peter J. Weiden, MD, PhD

03/01/2019
BACKGROUND: Significant delay can occur between the first dose of a long-acting injectable (LAI) antipsychotic and achievement of efficacious plasma concentrations, which is usually addre...
03/01/2019
OASIS was an observational study that evaluated real-world outcomes of atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Overall, CGI-S scores at basel...
10/26/2023